Application 209430
- Type
- ANDA
- Sponsor
- TARO
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DAPSONE | DAPSONE | TABLET;ORAL | 25MG | No | No |
| 002 | DAPSONE | DAPSONE | TABLET;ORAL | 100MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 51672-4197 | Dapsone | Dapsone | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |
| 51672-4198 | Dapsone | Dapsone | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |